Health24.com | Clues to why women have higher odds for Alzheimer’s

Rates of Alzheimer’s disease are higher in women than in men, and researchers now think they know why.

A team from Vanderbilt University Medical Center, in Nashville, Tennessee, has identified gender differences in how the Alzheimer’s-related protein tau spreads in the brain.

A graph analysis

Research suggests that tau spreads through the brain like an infection, moving from neuron to neuron and turning other proteins into abnormal tangles that result in the death of brain cells.

In this study, investigators used data from positron emission tomography (PET) scans of healthy people and patients with mild mental (cognitive) impairment to create a graph analysis of how tau spreads.

“It’s kind of like reconstructing a crime scene after a crime. You weren’t there when it happened, but you can determine where an intruder entered a house and what room they entered next,” said lead investigator Sepi Shokouhi, an assistant professor of psychiatry and behavioural sciences.

“The graph analysis does something similar to show how tau spreads from one region to another,” Shokouhi explained in a centre news release.

The researchers found that the structure of tau networks is different in men and women, with women having a larger number of “bridging regions” that connect various areas of the brain.

Further research needed

This may enable tau to spread more easily between brain regions, increasing the speed at which it accumulates and putting women at greater risk for Alzheimer’s disease, the investigators theorised.

The study was presented at the Alzheimer’s Association International Conference, in Los Angeles. Data presented at conferences is usually considered preliminary until published in a peer-reviewed medical journal.

Further research is needed to confirm that women have an accelerated spread of tau. If it’s proven, then sex-specific approaches may be needed to prevent Alzheimer’s, according to the researchers. This could include earlier treatment, lifestyle interventions and/or remedial help for memory.

“Understanding how different biological processes influence our memory is a really important topic,” Shokouhi said.

Image credit: iStock

Share Button

Health24.com | How to relieve dry, irritated eyes

Do all the ads for dry eye relief have you thinking you could have this condition? If you’ve ever felt like you had a grain of sand in your eye when nowhere close to the beach, you could be experiencing dry eye.

Exactly what is dry eye? Simply put, it’s when you aren’t making enough tears to keep the front surface of the eye lubricated, or your tears don’t have enough water in them. Eyes can feel gritty, scratchy or like they’re burning. You might even notice excess watering or blurred vision.

There’s a lot you can do

Tear production often lessens with age, but it can also be the result of a medical condition – not only eye diseases but also rheumatoid arthritis, diabetes and thyroid problems. It can also be a side effect of certain medications, including antihistamines, decongestants, blood pressure medications and antidepressants. Living in a dry, windy climate or just sitting in front of a cosy fireplace in winter can cause tears to evaporate.

There’s much you can do to restore the normal amount of tears, according to the American Optometric Association, starting with over-the-counter artificial tear solutions, or prescription eye drops or ointments. See your eye professional to discuss the options and find out what’s most appropriate for you.

Lifestyle changes can also help. Try getting more omega-3 fatty acids in your diet. Treat your eyes to warm compresses and massage your eyelids. If you wear contact lenses, new formulations might be more comfortable. Blink regularly when reading or working at a computer for long periods of time. Also, increase the humidity in the air at work and at home, wear sunglasses to shield eyes outdoors, and drink eight to 10 glasses of water each day to stay hydrated.

Image credit: iStock

Share Button

Repeat Caesareans ‘often safer birth option’

Mothers should be offered a choice of vaginal or Caesarean delivery and be told about the risks, say experts.

Share Button

Bats use private and social information as they hunt

In the arms race between predators and prey, each evolves more and more sophisticated ways of catching or escaping from the other. Rachel Page, staff scientist at the Smithsonian Tropical Research Institute and Ximena Bernal, associate professor at Purdue University, review in Functional Ecology how bats use both private and social information to attack their prey.

“Bats are an exciting group to study because they have evolved so many different hunting strategies,” said Page. “In this review, we look broadly across bats worldwide to investigate the patterns and processes underlying the sensory and cognitive adaptations bats have evolved to successfully hunt their prey.”

Bats hunting in open spaces, high above the forest or over water, depend primarily on their echolocation systems. When they receive an echo from a prey, they produce more and more frequent signals — producing what is called a feeding buzz — as they go in for the kill. In contrast, bats that hunt in more enclosed, cluttered spaces often cannot use echolocation alone to find their prey. The echoes that bounce off vegetation are difficult to distinguish from the echoes of the prey. These bats are very good at listening for sounds emitted by prey.

Bats from New Zealand, which forage up to 40% of the time hunting on the forest floor, listen for movement and use their sense of smell to detect prey in the leaf litter. Vampire bats are able to recognize the sounds of a specific individual’s breathing pattern, returning to feed on the same blood night after night. Desert-dwelling long-eared bats listen for the sounds made by scorpions as they move through the environment, and use these sounds to pinpoint their prey.

“Searching for prey takes a lot of time and energy, but one of the amazing things that bats do to minimize search effort is to eavesdrop on prey as they communicate — and also to eavesdrop on other bats to find out where they are catching prey,” said Bernal.

As male túngara frogs call, hoping to attract a mate, fringe-lipped bats perceive the mating calls as a dinner bell. Katydids also call to attract mates. Different bat species respond to different katydid calls, divvying up available food. And like the frogs, some moths also form groups of singing males to attract females — and end up attracting bats at the same time.

Bats observe other bats as they hunt, paying special attention to locations where bats are making feeding buzzes, indicating abundant patches of prey. Bats tend to have hearing abilities that match their hunting strategies. Bats relying purely on echolocation to find food tend to emit loud, far-reaching echolocation calls and have smaller ears, while gleaners have large ears, lower-frequency hearing and produce quieter echolocation calls. No matter which hunting strategy they use or where they hunt, bats seem to be adept at learning from one another. Not only do they learn from their own species, they also learn from other bat species.

“We are puzzled as we look at bat family trees to see where different hunting strategies have arisen as bats evolve,” said Page. “If so many bat species have low-frequency hearing and can thus detect prey mating signals, and these mating signals are excellent beacons of high density prey patches, why aren’t more bat species taking advantage of these loud, conspicuous signals?”

“Despite the fact that bats are an excellent group to learn about the sensory adaptations of predators, the vast majority of bats are poorly studied,” said Bernal. “Perhaps more research will help us to understand how predation strategies evolved. These are the questions that will drive new generations of students to keep looking for answers.”

Story Source:

Materials provided by Smithsonian Tropical Research Institute. Note: Content may be edited for style and length.

Share Button

Light-activated metal catalyst destroys cancer cells’ vital energy source

A space-age metal that formed part of the asteroid that destroyed the dinosaurs could provide a new method of treating cancer tumours selectively using light.

Scientists at the University of Warwick in collaboration with colleagues in China, France, Switzerland and Heriot-Watt University have developed a technique that uses light to activate a cancer-killing compound of Iridium that attacks, for the first time, a vital energy source in cancer cells even under hypoxia, significantly opening up the range of cancers that can be treated using the technique.

The technique is detailed in a paper published today (23 September 2019) in Nature Chemistry and could lead to another tool for clinicians to use in the fight against cancer, and potentially even vaccinate patients against future cancers.

Photodynamic therapy (PDT) uses light to kill cancer tumours in the body by activating a chemical compound called a photosensitiser, which creates species that can attack cancer cells in the presence of light. Using this method, clinicians can direct the light to specific regions of the cancer tumour and spare normal tissue from damage.

Current methods mainly rely on the presence of oxygen and many tumours are ‘hypoxic’, which means that they are deficient in normal oxygen often due to poor blood supplies. The international team of scientists have now developed a compound of the metal Iridium that will kill cancer cells in culture even when oxygen concentration is low.

The technique can treat any tumours where light can be administered, and would be particularly suited to treat bladder, lung, esophageal, brain and skin cancers. There are around 10,000 bladder cancer cases in the UK per year, of which about 5,000 might potentially benefit from this kind of treatment.

Professor Peter Sadler from the University of Warwick’s Department of Chemistry said: “All the time in cancer treatment, clinicians are trying to fight resistance. Drugs can kill the cancer cells initially, but with repeated treatment the cells become resistant, they learn how to chemically modify the drug or counteract its mechanism of action. Researchers are looking for novel ways in which the cancer cell will die. If they have become resistant to other cancer drugs, they may not be resistant to this treatment because the way it kills the cancer cells is different.

“There is an increasing interest in reducing the side effects of cancer treatment as much as possible and anything that can be selective in what it targets will help with that. The compound that we have developed would not be very toxic at all, we would give it to the cancer cells, allow a little time for it to be taken up, then we would irradiate it with light and activate it in those cells. We would expect killing of those cancer cells to occur very quickly compared with current methods.”

Once light-activated, the Iridium compound attacks the energy producing machinery in the cancer cells — a vital co-enzyme called nicotinamide adenine dinucleotide (NADH) — and catalytically destroys that co-enzyme or changes it into its oxidised form. This upsets the energy-producing machinery in a cancer cell and effectively cuts off the tumour’s power source.

Our bodies need coenzyme nicotinamide adenine dinucleotide (NADH) to generate energy. Cancer cells have a very high requirement for NADH, because they need a lot of energy to divide and multiple rapidly.

The researchers even found that the compound still works in the presence of oxygen, by converting it into a ‘toxic’ type of oxygen that will kill the cancer cells.

The team of scientists also noted that as the cancer cells die, they change their chemistry in such a way that they will generate an immune reaction in the body, what is known as an immunotherapeutic response. This suggests that those treated by this technique might be immunised against attack by that cancer, and will be investigated further in future research.

Professor Vas Stavros (University of Warwick) commented: “The power of light to change the reactivity of chemical molecules dramatically within a thousandth of a millionth of a second can now be harnessed to treat resistant cancers.”

Professor Martin Paterson (Heriot-Watt University) commented: “This breakthrough illustrates the power of modern computation to understand the effects of light on chemical molecules to provide drugs of the future with truly unique mechanisms of action.”

Professor Hui Chao (Sun Yat-Sen University) commented: “Now we have a potential new drug which can not only selectively kill cancer cells with normal oxygen supplies, but also hypoxic cancer cells which often resist treatment by photodynamic therapy.”

Professor Peter Sadler added: “The ability of metal compounds to induce an immunogenic response in the body that may effectively vaccinate a person against future attack by cancer is an exciting development. It is very speculative, but we are looking further into the hallmarks of that.

“Importantly we were fortunate to have had 3 highly talented young Royal Society Newton International Fellows in our team working on this challenging interdisciplinary project, who will undeniably contribute towards the future of this crucially important research.”

Iridium was first discovered in 1803, and its name comes from the Latin for ‘rainbow’. From the same family as platinum, it is hard, brittle, and is the world’s most corrosion-resistant metal. Yellow in colour, its melting point is more than 2400° Celsius. It is used in satellites and spacecraft due to its resistance to extreme environments, and is commonly believed to have been enriched in the earth’s crust by a meteorite that wiped out the dinosaurs 66 million years ago.

Share Button

New CRISPR class expands genetic engineering toolbox

Biomedical engineers at Duke University have used a previously unexplored CRISPR technology to accurately regulate and edit genomes in human cells.

With this new approach, the researchers hope to dramatically expand the CRISPR-based tools available to biomedical engineers, opening up a new and diverse frontier of genome engineering technologies.

In a study appearing on Sept. 23 in Nature Biotechnology, Charles Gersbach, the Rooney Family Associate Professor of Biomedical Engineering at Duke, and Adrian Oliver, a post-doctoral fellow in the Gersbach lab who led the project, describe how they successfully harnessed Class 1 CRISPR systems to turn target genes on and off and edit the epigenome in human cells for the first time.

CRISPR-Cas is a defense system in which bacteria use RNA molecules and CRISPR-associated (Cas) proteins to target and destroy the DNA of invading viruses. The discovery of this phenomenon and the repurposing of the molecular machinery set off a genome-editing revolution as researchers learned how to wield the tool to specifically target and edit DNA in human cells.

CRISPR-Cas9, the most commonly used genome editing tool today, is categorized as a Class 2 CRISPR system. Class 2 systems are less common in the bacterial world, but they are theoretically simpler to work with, as they rely on only one Cas protein to target and cleave DNA.

Class 1 systems are not so simple, relying on multiple proteins working together in a complex called Cascade (CRISPR-associated complex for antiviral defense) to target DNA. After binding, Cascade recruits a Cas3 protein that cuts the DNA.

“If you were to look at the individual CRISPR systems of all the bacteria in the world, nearly 90 percent are Class 1 systems,” said Gersbach. “CRISPR-Cas biology is an incredible source for biotechnology tools, but until recently everyone has only been looking at a small slice of the pie.”

To demonstrate the capabilities of the Class 1 system, Oliver attached gene activators to specific sites along a type I E. coli Cascade complex and targeted the system to bind gene promoters, which regulate gene expression levels. Because she did not include the Cas3 protein in the experiment, there was no cutting of the DNA and no change to underlying DNA sequence. The experiment showed that the Cascade activator not only binds to the correct site and can turn up the levels of the target gene, but does so with accuracy and specificity comparable to CRISPR/Cas9.

Oliver repeated the process using type I Cascade complexes from an additional bacterial strain that was particularly robust in working at a variety of target sites. She also showed that the activator domain could be swapped for a repressor to turn target genes off. Again, the researchers noted accuracy and specificity comparable to CRISPR/Cas9 methods.

“We have found Cascade’s structure to be remarkably modular, allowing for a variety of sites to attach activators or repressors, which are great tools for altering gene expression in human cells,” Oliver said. “The flexible nature of Cascade makes it a promising genome engineering technology.”

Gersbach and Oliver were encouraged to investigate the more complicated Class 1 CRISPR systems by their collaborators at nearby North Carolina State University, Professors Rodolphe Barrangou and Chase Beisel, who is now at the Helmholtz Centre for Infection Research in Germany. Barrangou is a microbiologist who has studied the natural biology of diverse CRISPR defense mechanisms for nearly two decades, and Beisel is a chemical engineer who has worked with Barrangou on engineering microorganisms with Class 1 CRISPR systems. They were both curious whether Gersbach’s lab could use these systems in human cells similar to their work with Cas9.

“This work and the resulting technologies are a fantastic example of how collaboration across disciplines and across universities in the North Carolina Research Triangle can be highly innovative and productive” says Barrangou, the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University.

Now, the team is optimistic that their study, and the related work of others in the field, will incentivize new research into Class 1 CRISPR systems.

“The purpose of this project was to explore the diversity of CRISPR systems,” said Gersbach. “There have been thousands of papers about CRISPR-Cas9 in the last decade, and yet we’re constantly learning new things about it. With this study we’re applying that mindset to the other 90% of what’s out there.”

So far, the team has shown that these Class 1 systems are comparable to to CRISPR-Cas9 in terms of accuracy and application. As they consider future directions, they are curious to explore how these systems differ from their Class 2 counterparts, and how these differences could prove useful for biotechnology applications.

The team is also interested in studying how Class 1 systems could address general challenges for CRISPR-Cas research, especially issues that complicate potential therapeutic applications, like immune responses to Cas proteins and concurrently using multiple types of CRISPR for different genome engineering functions.

“We know CRISPR could have a big impact on human health,” said Gersbach. “But we’re still at the very beginning of understanding how CRISPR is going to be used, what it can do, and what systems are available to us. We expect that this new tool will enable new areas of genome engineering.”

Share Button

Are Scots becoming more or less healthy?

Seven charts from the latest Scottish Health Survey looking at drinking, smoking and exercise.

Share Button

Health24.com | The return of a training classic for runners

With running, proper form is essential for everything from desired speed to injury prevention. But for many people, muscle memory has locked in less-than-perfect form.

A very simple technique, popularised in the 19th century by chemist-turned-runner W.G. George and re-introduced a few years ago by reporter and author Christopher McDougall, offers a re-set. Known as the 100-Up, it involves two stages.

The Minor

First you need to master the Minor – 30 knee raises, much like marching in place, done with perfect form.

Stand with shoulders over hips over ankles, feet about eight inches (about 20cm) apart.

Then bring your left knee forward and up to hip level as you press your left elbow back behind you. Return to start and repeat up to 30 times.

Then repeat with the right knee.

Be sure to land lightly on the ball of your foot, not the heel. It’s a rhythmic movement: Don’t lock joints or hunch forward for momentum.

Seems simple enough, but you may only be able to do 10 before your posture slips or you can’t raise your knee high enough.

George described it as balancing on one leg while working the other. A current variation is to alternate legs and build up to 100 raises in total, 50 per side.

Once you can correctly do the 30 with each leg, repeat the exercise at a faster speed for the second stage, the Major.

The Major

Balance on the balls of your feet, heels just off the ground and your head and body tilted very slightly forward.

Spring from the toes, bringing one knee to the level of the hip, then letting the foot fall back to its original position.

Repeat with the other leg and continue raising and lowering the legs alternately. This action is exactly that of running except that you do it in place rather than moving forward.

Again, build gradually until you can do 100 with perfect form.

For both the Minor and the Major, it’s fine to use your arms to help with force so that the upper body works in union with your legs.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | At-risk men may also benefit from regular mammograms

Mammography has saved hundreds of thousands of lives by detecting breast cancer early in women.

Could such regular X-ray screening also help men?

Genetics, race or ethnicity

A new study argues there’s potential benefit in regular mammograms for men who are at high risk of breast cancer.

Mammography accurately detected dozens of cases of breast cancer in nearly 1 900 men screened during a 12-year period, results show.

These men were at increased risk of breast cancer due to their genetics, race or ethnicity, prior radiation exposure, hormone imbalances or other medical factors, said lead researcher Dr Yiming Gao, an assistant professor of radiology at NYU Langone Medical Center in New York City.

“Mammography screening has helped detect breast cancer early in women, and we have shown it can do the same for men,” Gao said.

The study also found that men who already had breast cancer were 84 times more likely than others to get it again. And men with an immediate relative such as a sister or mother who had breast cancer had triple the risk.

Breast cancer is much rarer in men than women. About 2 670 breast cancers will be diagnosed in men this year, compared with 268 600 new cases diagnosed in women, said Robert Smith, vice president of cancer screening for the American Cancer Society.

Men don’t do as well

But because men aren’t regularly screened, male breast cancer tends to be diagnosed when it’s reached a more advanced stage, Gao said.

“For this reason, men with breast cancer often do not do as well as women,” she said. “More men die from breast cancer than from testicular cancer according to American Cancer Society estimates, although the latter is more common.”

To see whether mammograms might help detect breast cancer in men, Gao and her team studied 1 869 male patients who had more than 2 000 X-ray screenings between 2005 and 2017.

The men sought testing either because they felt a lump in their breast or because a family member had recently been diagnosed with the disease.

The exams found about 2 300 breast lesions, which resulted in 149 biopsies in 133 men. In all, 41 malignant breast tumours were detected.

That might not sound like much, but mammography actually proved more accurate for men than for women, researchers said.

More research needed

For every 1 000 exams in high-risk men, 18 had breast cancer. The detection rate for women is roughly 5 for every 1 000 exams.

Men have less breast tissue than women, and more breast tissue can mask small tumours, researchers said.

Although this study showed the promise of mammography for high-risk men, more research is needed before any guidelines can be issued, Gao said.

Right now, there’s no way to know when these men should start having mammograms, and how often they should undergo screening, she said.

“Our available data allows us to determine that targeted mammography screening in high-risk men is worthwhile,” Gao said. “However, a lot more data are needed to get to more nuanced information before we are able to make meaningful recommendations.”

Very, very low risk

Smith agreed that the findings suggest that “serious consideration be given to recommending regular breast imaging for men at very high risk”.

However, it wouldn’t make sense to have all men receive regular mammograms, he added.

“While the average woman can be judged to be at high enough risk – about 12% over her lifetime – of breast cancer to undergo regular screening after age 40 or 45, it would be very unproductive to screen average-risk men, who have a very, very low risk of breast cancer,” Smith said.

The new study was published in the journal Radiology.

Image credit: iStock

Share Button

Health24.com | Can you still be healthy if you’re overweight?

If you’re overweight but have dodged chronic health issues like high cholesterol and high blood pressure, you might not think that losing weight is a priority. But an analysis of five years of records on 3.5 million people – underweight, normal weight, overweight and obese – has found reason for concern.

Normal weight no guarantee

The researchers discovered that even if people didn’t have any metabolic diseases at the start of the record-keeping, those who were obese were more likely than those of normal weight to develop health issues as time went on. Those health issues include coronary heart disease, cerebrovascular disease, heart failure and peripheral vascular disease (a circulation disorder that affects blood vessels beyond the brain and heart).

But no one is completely immune to health problems. Researchers also found that being at a normal weight doesn’t necessarily eliminate all risk for metabolic abnormalities, like high blood pressure, high cholesterol and diabetes. Indeed, 10% of those at a normal weight had at least one metabolic issue. Also, no matter what your weight, the more of those health markers you have, the greater your chances of a heart event, like an attack.

This research underscores the importance of getting regular health screenings and knowing your numbers: cholesterol (total, HDL and LDL) and triglycerides; blood pressure (systolic and diastolic); and blood sugar. Then you can work with your health care provider on lifestyle changes to improve your health and risk factors, whether or not weight loss needs to be part of the plan.

Image credit: iStock

NEXT ON HEALTH24X

Share Button